We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.07%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$308M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$188M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$172M
4
PSA icon
Public Storage
PSA
+$47.9M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$46.9M

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$53.7M
2
MCD icon
McDonald's
MCD
+$46.3M
3
SO icon
Southern Company
SO
+$33.8M
4
HEWJ icon
iShares Currency Hedged MSCI Japan ETF
HEWJ
+$26.3M
5
ETP
Energy Transfer Partners L.p.
ETP
+$24.9M

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVS icon
101
Novartis
NVS
$301B
$93.2M 0.2%
1,246,630
-757,868
-38% -$53.7M
DD icon
102
DuPont de Nemours
DD
$18.7B
$92.4M 0.2%
578,796
+9,014
+2% +$1.43M
EPD icon
103
Enterprise Products Partners
EPD
$82.5B
$92M 0.2%
3,398,743
+65,198
+2% +$1.77M
PX
104
DELISTED
Praxair Inc
PX
$91.9M 0.2%
693,614
+41,711
+6% +$5.35M
TFC icon
105
Truist Financial
TFC
$63.5B
$91.1M 0.2%
2,006,634
+32,980
+2% +$1.43M
JCI icon
106
Johnson Controls International
JCI
$87.8B
$89.1M 0.19%
2,053,781
+85,477
+4% +$3.58M
SHM icon
107
State Street SPDR Nuveen ICE Short Term Municipal Bond ETF
SHM
$3.46B
$88.4M 0.19%
1,823,070
+171,838
+10% +$8.35M
BIIB icon
108
Biogen
BIIB
$30.7B
$87.9M 0.19%
324,069
+13,755
+4% +$3.64M
VEA icon
109
Vanguard FTSE Developed Markets ETF
VEA
$230B
$86.7M 0.19%
2,097,696
+137,912
+7% +$5.62M
IRM icon
110
Iron Mountain
IRM
$37.1B
$86.5M 0.19%
2,517,790
+70,258
+3% +$2.46M
VTR icon
111
Ventas
VTR
$44.7B
$86.4M 0.19%
1,243,768
-100,364
-7% -$6.68M
EFG icon
112
iShares MSCI EAFE Growth ETF
EFG
$16.7B
$85.9M 0.19%
1,161,164
+110,999
+11% +$8.11M
REET icon
113
iShares Global REIT ETF
REET
$5.12B
$84.6M 0.18%
3,324,448
+407,706
+14% +$10.5M
ADSK icon
114
Autodesk
ADSK
$49.6B
$83.8M 0.18%
830,858
+34,497
+4% +$3.41M
C icon
115
Citigroup
C
$222B
$83.7M 0.18%
1,251,332
+149,443
+14% +$9.17M
TXN icon
116
Texas Instruments
TXN
$255B
$82.2M 0.18%
1,068,648
-146,175
-12% -$11.7M
RTN
117
DELISTED
Raytheon Company
RTN
$80.2M 0.17%
496,672
+29,796
+6% +$4.72M
VCSH icon
118
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.8B
$80M 0.17%
999,462
+19,507
+2% +$1.56M
WY icon
119
Weyerhaeuser
WY
$16.9B
$78.2M 0.17%
2,333,302
+104,810
+5% +$3.53M
ADP icon
120
Automatic Data Processing
ADP
$105B
$77.2M 0.17%
753,687
+27,874
+4% +$2.82M
EMR icon
121
Emerson Electric
EMR
$83.3B
$75.5M 0.16%
1,266,049
+27,153
+2% +$1.61M
MET icon
122
MetLife
MET
$62.5B
$75.3M 0.16%
1,537,036
+33,470
+2% +$1.55M
RTX icon
123
RTX Corp
RTX
$289B
$73.3M 0.16%
953,567
+35,154
+4% +$2.63M
FVD icon
124
First Trust Value Line Dividend Fund
FVD
$8.33B
$72.7M 0.16%
2,483,940
+458,511
+23% +$13.4M
UL icon
125
Unilever
UL
$141B
$72.4M 0.16%
1,189,009
-110,012
-8% -$6.56M
3 4
5
6 7

Similar funds

RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
ECU
Eisler Capital (UK) London, United Kingdom $21.7B AUM 0.34% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AA
Axiom Advisory San Diego, California $10.7B AUM 25.51% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.